Jmac Enterprises LLC bought a new stake in DuPont de Nemours, Inc. (NYSE:DD – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,300 shares of the basic materials company’s stock, valued at approximately $559,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp raised its position in DuPont de Nemours by 140.3% during the 2nd quarter. State Street Corp now owns 44,941,824 shares of the basic materials company’s stock worth $6,095,909,000 after buying an additional 26,238,300 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of DuPont de Nemours by 22.0% in the first quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company’s stock valued at $212,039,000 after acquiring an additional 835,572 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of DuPont de Nemours by 10.0% in the first quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company’s stock valued at $169,762,000 after acquiring an additional 336,780 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of DuPont de Nemours by 4.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company’s stock worth $160,688,000 after acquiring an additional 163,210 shares during the period. Finally, Amundi raised its holdings in DuPont de Nemours by 31.3% during the first quarter. Amundi now owns 2,478,630 shares of the basic materials company’s stock worth $113,526,000 after purchasing an additional 591,011 shares in the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the stock. Royal Bank Of Canada reduced their price objective on shares of DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a research report on Thursday, October 15th. The Goldman Sachs Group dropped their target price on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research report on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $172.00 to $145.00 in a research note on Friday, October 9th. Zacks Research cut DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. Finally, Citigroup lifted their price target on DuPont de Nemours from $162.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday. Twelve investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.75.
Check Out Our Latest Analysis on DD
Key DuPont de Nemours News
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Analysts raised their targets and kept bullish ratings. UBS lifted its target to $182 and maintained a Buy rating; Citigroup raised its target to $176 with a Buy rating; and Barclays raised its target to $176 with an Overweight rating. UBS rating information Citigroup rating information Barclays rating information
- Positive Sentiment: Q3 results beat expectations and growth was broad-based. DuPont reported adjusted EPS of $2.09 versus the $1.87 consensus and revenue of about $1.9 billion, up 4% year over year; organic sales increased 5%. The company cited strong healthcare and aerospace demand. Reuters report on DuPont’s outlook
- Positive Sentiment: DuPont raised its 2026 outlook and plans further buybacks. After exceeding its third-quarter guidance, the company increased its full-year guidance and announced plans to repurchase $250 million of shares in the fourth quarter, supporting the investment case. DuPont third-quarter results
- Neutral Sentiment: A new peptide-purification product could offer a growth opportunity, but the supplied article listing does not provide enough detail to assess its likely revenue contribution. Article on DuPont’s peptide-purification product
- Negative Sentiment: DD has softened after its earnings-related surge. The coverage provided does not point to a specific adverse catalyst, so the pullback may reflect profit-taking rather than a deterioration in the reported business outlook.
DuPont de Nemours Stock Performance
Shares of DD opened at $151.15 on Thursday. The company has a quick ratio of 1.82, a current ratio of 2.36 and a debt-to-equity ratio of 0.23. DuPont de Nemours, Inc. has a 52-week low of $111.15 and a 52-week high of $157.98. The company has a 50-day simple moving average of $132.93 and a 200-day simple moving average of $138.62. The company has a market capitalization of $20.41 billion, a PE ratio of 67.78, a P/E/G ratio of 1.37 and a beta of 1.06.
DuPont de Nemours (NYSE:DD – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.22. DuPont de Nemours had a net margin of 4.26% and a return on equity of 6.85%. The firm had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.09 earnings per share. The firm’s revenue was up 4.1% on a year-over-year basis. Equities research analysts predict that DuPont de Nemours, Inc. will post 7.49 earnings per share for the current fiscal year.
DuPont de Nemours Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 annualized dividend and a dividend yield of 1.6%. DuPont de Nemours’s payout ratio is 533.33%.
DuPont de Nemours Profile
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Featured Articles
- Five stocks we like better than DuPont de Nemours
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
